130 related articles for article (PubMed ID: 16458795)
1. Hierarchical modeling and other spatial analyses in prostate cancer incidence data.
Mather FJ; Chen VW; Morgan LH; Correa CN; Shaffer JG; Srivastav SK; Rice JC; Blount G; Swalm CM; Wu X; Scribner RA
Am J Prev Med; 2006 Feb; 30(2 Suppl):S88-100. PubMed ID: 16458795
[TBL] [Abstract][Full Text] [Related]
2. Spatial-temporal analysis of prostate cancer incidence from the Pennsylvania Cancer Registry, 2000-2011.
Wang M; Matthews SA; Iskandarani K; Li Y; Li Z; Chinchilli VM; Zhang L
Geospat Health; 2017 Nov; 12(2):611. PubMed ID: 29239571
[TBL] [Abstract][Full Text] [Related]
3. Spatial analysis of prostate cancer incidence and race in Virginia, 1990-1999.
Oliver MN; Smith E; Siadaty M; Hauck FR; Pickle LW
Am J Prev Med; 2006 Feb; 30(2 Suppl):S67-76. PubMed ID: 16458792
[TBL] [Abstract][Full Text] [Related]
4. Temporal and spatial trends and determinants of aggressive prostate cancer among Black and White men with prostate cancer.
Wang M; Chi G; Bodovski Y; Holder SL; Lengerich EJ; Wasserman E; McDonald AC
Cancer Causes Control; 2020 Jan; 31(1):63-71. PubMed ID: 31732913
[TBL] [Abstract][Full Text] [Related]
5. Impact of socioeconomic inequalities on geographic disparities in cancer incidence: comparison of methods for spatial disease mapping.
Goungounga JA; Gaudart J; Colonna M; Giorgi R
BMC Med Res Methodol; 2016 Oct; 16(1):136. PubMed ID: 27729017
[TBL] [Abstract][Full Text] [Related]
6. Geographical, temporal and racial disparities in late-stage prostate cancer incidence across Florida: a multiscale joinpoint regression analysis.
Goovaerts P; Xiao H
Int J Health Geogr; 2011 Dec; 10():63. PubMed ID: 22142274
[TBL] [Abstract][Full Text] [Related]
7. Spatial patterns of localized-stage prostate cancer incidence among white and black men in the southeastern United States, 1999-2001.
Altekruse SF; Huang L; Cucinelli JE; McNeel TS; Wells KM; Oliver MN
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1460-7. PubMed ID: 20501756
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer incidence and tumor severity in Georgia: descriptive epidemiology, racial disparity, and geographic trends.
Wagner SE; Bauer SE; Bayakly AR; Vena JE
Cancer Causes Control; 2013 Jan; 24(1):153-66. PubMed ID: 23179658
[TBL] [Abstract][Full Text] [Related]
9. Race-specific geography of prostate cancer incidence.
DeChello LM; Gregorio DI; Samociuk H
Int J Health Geogr; 2006 Dec; 5():59. PubMed ID: 17176460
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008.
Cook MB; Rosenberg PS; McCarty FA; Wu M; King J; Eheman C; Anderson WF
Prostate; 2015 May; 75(7):758-63. PubMed ID: 25619191
[TBL] [Abstract][Full Text] [Related]
11. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
[TBL] [Abstract][Full Text] [Related]
12. Spatially-explicit survival modeling with discrete grouping of cancer predictors.
Onicescu G; Lawson AB; Zhang J; Gebregziabher M; Wallace K; Eberth JM
Spat Spatiotemporal Epidemiol; 2019 Jun; 29():139-148. PubMed ID: 31128623
[TBL] [Abstract][Full Text] [Related]
13. Recent changes in the spatial pattern of prostate cancer in the U.S.
Rogerson PA; Sinha G; Han D
Am J Prev Med; 2006 Feb; 30(2 Suppl):S50-9. PubMed ID: 16458790
[TBL] [Abstract][Full Text] [Related]
14. High prostate cancer mortality in Poland. A spatial, temporal and structural analysis.
Czaderny K
Przegl Epidemiol; 2018; 72(2):235-246. PubMed ID: 30111069
[TBL] [Abstract][Full Text] [Related]
15. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
16. Statewide analysis of serum prostate specific antigen levels in Louisiana men without prostate cancer.
Kyle C; Ewing T; Wu XC; Mercante D; Lifsey D; Meunier C; Jefferson L; Sartor O; Rayford W
J La State Med Soc; 2004; 156(6):319-23. PubMed ID: 15688673
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and utility of mapping disease risk at the neighbourhood level within a Canadian public health unit: an ecological study.
Holowaty EJ; Norwood TA; Wanigaratne S; Abellan JJ; Beale L
Int J Health Geogr; 2010 May; 9():21. PubMed ID: 20459738
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the performance of tests for spatial randomness on prostate cancer data.
Hinrichsen VL; Klassen AC; Song C; Kulldorff M
Int J Health Geogr; 2009 Jul; 8():41. PubMed ID: 19575788
[TBL] [Abstract][Full Text] [Related]
19. Geospatial and temporal variation of prostate cancer incidence.
Wah W; Ahern S; Evans S; Millar J; Evans M; Earnest A
Public Health; 2021 Jan; 190():7-15. PubMed ID: 33321358
[TBL] [Abstract][Full Text] [Related]
20. Clusters of census tracts with high proportions of men with distant-stage prostate cancer incidence in New Jersey, 1995 to 1999.
Abe T; Martin IB; Roche LM
Am J Prev Med; 2006 Feb; 30(2 Suppl):S60-6. PubMed ID: 16458791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
